A detailed history of Intech Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Intech Investment Management LLC holds 484,379 shares of BMY stock, worth $25.8 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
484,379
Previous 704,607 31.26%
Holding current value
$25.8 Million
Previous $38.2 Million 47.35%
% of portfolio
0.25%
Previous 0.54%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$40.25 - $52.99 $8.86 Million - $11.7 Million
-220,228 Reduced 31.26%
484,379 $20.1 Million
Q1 2024

May 10, 2024

BUY
$47.98 - $54.4 $15.1 Million - $17.1 Million
314,732 Added 80.73%
704,607 $38.2 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $13.8 Million - $16.4 Million
-283,629 Reduced 42.11%
389,875 $20 Million
Q3 2023

Nov 13, 2023

SELL
$57.89 - $64.73 $37.7 Million - $42.2 Million
-651,245 Reduced 49.16%
673,504 $39.1 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $36.4 Million - $40.4 Million
-571,152 Reduced 30.13%
1,324,749 $84.7 Million
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $1.34 Million - $1.52 Million
-20,407 Reduced 1.06%
1,895,901 $131 Million
Q4 2022

Feb 09, 2023

SELL
$68.48 - $81.09 $6.49 Million - $7.69 Million
-94,780 Reduced 4.71%
1,916,308 $138 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $41,012 - $24.2 Million
315,484 Added 18.61%
2,011,088 $143 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $123 Million - $136 Million
1,695,604 New
1,695,604 $131 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.